Pulmonary embolism (PE) is a serious medical condition in which a blood clot blocks one of the arteries in the lungs. It can be life-threatening and is a leading cause of death in the United States. The impact of PE on life expectancy can be significant, and it is important for doctors to understand the diagnosis and treatment of this condition. This article will explore the impact of PE on life expectancy, including the risk factors, diagnosis, and treatment options.
PE is more common in certain populations than others. People who are at an increased risk of developing PE include those who are over the age of 60, those who have had recent surgery, those who have been immobile for a long period of time, those who have had a recent injury, those who have had a recent heart attack or stroke, and those who have a family history of PE. Additionally, certain medical conditions such as cancer, heart failure, and deep vein thrombosis (DVT) can increase the risk of PE.
The diagnosis of PE is based on a combination of clinical evaluation, laboratory tests, and imaging studies. The most common laboratory test used to diagnose PE is a D-dimer test, which measures the amount of a protein that is released when a blood clot is present. Other tests that may be used to diagnose PE include a chest X-ray, a computed tomography (CT) scan, and an echocardiogram.
Once a diagnosis of PE has been made, the treatment options will depend on the severity of the condition. The primary treatment for PE is anticoagulant therapy, which helps to prevent the formation of new blood clots. Anticoagulant therapy is typically given in the form of injections or pills. In some cases, surgery may be recommended to remove the clot and restore blood flow.
The impact of PE on life expectancy can be significant. People who have had a PE are at an increased risk of developing another PE, or of having a stroke or heart attack. Additionally, those who have had a PE are more likely to have long-term complications such as chronic pulmonary hypertension, which can reduce life expectancy.
Pulmonary embolism is a serious medical condition that can have a significant impact on life expectancy. It is important for doctors to understand the risk factors, diagnosis, and treatment options for PE in order to provide the best possible care for their patients. With proper diagnosis and treatment, the impact of PE on life expectancy can be minimized.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
Obesity linked to subsequent neoplasms in childhood cancer survivors
3.
Reducing social media to an hour a day boosts young people's self-image.
4.
Prostate Cancer Treatment Associated With Long-Term Complications
5.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
1.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
2.
Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells
3.
Hope in Numbers: Understanding AML Leukemia Survival Rates and Emerging Therapies
4.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
5.
Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Current Scenario of Cancer- Q&A Session to Close the Gap
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation